In this episode we discuss the 3 keys to sales success: persistence, kindness, and gratitude

Robert Castaneda joins us once again to discuss the success he has had promoting onychomycosis (nail fungus) testing to primary care and medical spas.

Joyce Pitters-Hinds from Allos joins us to discuss her very profitable allergy solution

In this podcast, Viv talks with Melissa Conley on in-office PCR testing. Lab testing is in the foremost of people's minds right now. Melissa is sharing what is available to practices and what the opportunity for testing in the future will be COVID-19.

#inofficePCR #PCR #labs

In this episode, Mike and Viv discuss the role ancillaries can play in helping physicians. Burnout is a common problem among doctors and the addition of ancillary can help doctors in more ways than providing revenue.

In this podcast, Mike and Viv talk to David Carter about allergy and how their full service solution helps practices grow their bottom line. Most ancillary reps have worked with allergy in the past with mixed success. Learn why this is still an attractive solution for sales reps and doctors.

No ancillary portfolio would be complete without Chronic Care Management. Viv and Mike discuss a turnkey option for your providers to easily take advantage of this CMS program.

In this episode, Mike and Viv talk to Bryndon Preston with RHSS on the exciting field of regenerative medicine. Stem Cell therapy is offering a new cash based regenerative solution to both doctors and patients to help accelerate the powerful healing properties of the body. Bryndon talks about what his company has to offer to help doctors be successful in this field.

We are excited to announce the launch of our new podcast, Medical Ancillary Trends. This podcast will be part of the Medical Practice Trends Podcast. This is physician-facing, so it's a great resource for your clients.

December can be a challenging month as a medical sales rep. Mike and Viv discuss some programs that you may have success with in the final month of the year.